Comparison of pirfenidone and corticosteroid treatments at the COVID‐19 pneumonia with the guide of artificial intelligence supported thoracic computed tomography

Abstract

Antifibrotic agents can reduce fibrosis that may develop in the future. These can also help dose reduction and/or non-use strategy for methylprednisolone therapy, which has many side effects. Further large series and randomised controlled studies are needed on this subject.